PABA (ácido para-aminobenzoico)

Condiciones de salud que PABA (ácido para-aminobenzoico) puede ayudar a apoyar.

• HipocondríaCientífico

  PABA has demonstrated reactive oxygen species (ROS) scavenging activity in laboratory studies, including reaction with hypochlorite and hydroxyl radicals, and protection of DNA from UV and free radical damage. It is described as having mild anti-inflammatory activity partly attributable to antioxidant mechanisms. PABA also may boost antioxidant enzyme activity. Human clinical antioxidant data are lacking.

• EccemaCientífico

  PABA has been investigated in human studies for rheumatoid arthritis, primarily in combination with cortisone or aspirin. A 1954 study in 31 patients treated for one year with PABA plus cortisone found benefit comparable to higher-dose cortisone alone. A 1953 study also reported that PABA combined with acetylsalicylic acid produced beneficial effects in active rheumatoid arthritis. Evidence is old and uncontrolled.

• Contaminación ElectromagnéticaCientífico

  PABA holds FDA approval for dermatomyositis and has been used clinically in scleroderma, lupus erythematosus, and morphea—all autoimmune conditions. Its proposed mechanism includes modulation of fibroblast activity and, as shown in in vitro studies, induction of endogenous interferon, which plays a central role in autoimmune pathophysiology. Results across these conditions are mixed and evidence is mostly from older, small, or uncontrolled studies.

• Ira (excesiva)Científico

  PABA's potassium salt (Potaba) has been evaluated in human clinical trials for connective tissue diseases including scleroderma, dermatomyositis, and Peyronie's disease. It is believed to work by inhibiting fibroblast glycosaminoglycan secretion and stabilizing monoamine oxidase A activity. FDA approval exists for scleroderma and morphea, though clinical trial results are mixed and evidence of benefit is limited.

• Vista (deficiente)Científico

  PABA has FDA approval for dermatomyositis—a skin and muscle autoimmune condition characterized by inflammatory skin involvement. It has also been used for morphea, pemphigus, and lichen sclerosis. Clinical evidence supporting these uses is limited and largely derived from old, uncontrolled studies. Topical PABA itself is a known skin sensitizer that can cause contact dermatitis.

• Mordeduras y PicadurasCientífico

  PABA (as Potaba) has been evaluated in Peyronie's disease, a connective tissue disorder of the tunica albuginea causing penile curvature, pain, and erectile dysfunction. A randomized placebo-controlled trial of 103 men over 12 months found higher response rates and significant plaque size reduction with Potaba versus placebo. The European Association of Urology gives a Grade B recommendation for its use in reducing plaque size and pain.

• Dolor de cabeza (tensión)Científico

  PABA has been specifically investigated in small human studies for rheumatoid arthritis, where it was combined with cortisone or aspirin. Studies from the early 1950s reported significant symptomatic benefit in active RA patients. In vitro data show potassium para-aminobenzoate inhibits glycosaminoglycan secretion in rheumatoid synovial cells. All human studies are old and uncontrolled.

• QuistesCientífico

  PABA is an FDA-approved UV filter used topically in sunscreens since the 1940s–1950s, absorbing UVB radiation to prevent sunburn. It is listed as an active sunscreen ingredient under FDA monograph categories. Its topical use for sun protection is well-established, though it has largely been replaced in modern sunscreens due to allergy concerns.

• Sangrado (externo)Tradicional

  PABA has been used historically for female infertility, reportedly by enhancing estrogenic activity. A 1942 uncontrolled case series by Sieve reported that 16 women with fertility problems who took 100 mg four times daily for 3–7 months had a 75% pregnancy rate. No rigorous controlled trials have replicated or followed up on this finding.

• Senos (hinchazón y sensibilidad)Tradicional

  PABA (para-aminobenzoic acid) has a longstanding traditional use in nutritional medicine as a component of hair color restoration and prevention of premature graying, with historical claims dating to the 1940s. It was used in early oral formulations for diffuse hair loss; however, high-quality modern RCT evidence for hair growth or thickness specifically is absent. Traditional nutritional medicine documented pigmentation restoration in several early case reports.

• FiebreTradicional

  PABA has been used traditionally to prevent hair loss and to restore gray hair to its natural color. Clinical reports from the 1940s–1950s documented hair re-pigmentation in patients receiving PABA for other conditions such as scleroderma and dermatomyositis; the effect was reversible upon discontinuation. No controlled studies on hair loss prevention or restoration exist.

• PulgasTradicional

  PABA is occasionally used by IBS sufferers for gastrointestinal symptoms. This use is documented in reference sources including Wikipedia's entry on 4-aminobenzoic acid, which notes pill-form use among IBS patients. No clinical trials specifically investigating PABA for IBS have been identified.

• SofocosTradicional

  PABA has been historically proposed as a vitiligo treatment based on a 1942 clinical observation by Sieve reporting pigmentation effects. However, the original study lacked a control group and its results are not considered meaningful by modern systematic review standards. One subsequent study suggested high oral PABA doses may paradoxically cause vitiligo. It is not currently recommended.

Sistemas corporales que PABA (ácido para-aminobenzoico) puede ayudar a apoyar.

• No hay sistemas corporales disponibles.